Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis

J.T. Phillips; G. Giovannoni; F.D. Lublin; P.W. O'Connor; C.H. Polman; E. Willoughby; W. Aschenbach; A. Pace; R. Hyde; F.E. Munschauer

doi:https://doi.org/10.1177/1352458511399611

Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis

J.T. Phillips, G. Giovannoni, F.D. Lublin, P.W. O'Connor, C.H. Polman, E. Willoughby, W. Aschenbach, A. Pace, R. Hyde, F.E. Munschauer

Neurology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

88 Citations (Scopus)

Original language	English
Pages (from-to)	970-979
Journal	MULTIPLE SCLEROSIS
Volume	17
Issue number	8
DOIs	https://doi.org/10.1177/1352458511399611
Publication status	Published - 2011

Access to Document

https://doi.org/10.1177/1352458511399611

Cite this

Phillips, J. T., Giovannoni, G., Lublin, F. D., O'Connor, P. W., Polman, C. H., Willoughby, E., Aschenbach, W., Pace, A., Hyde, R., & Munschauer, F. E. (2011). Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis. MULTIPLE SCLEROSIS, 17(8), 970-979. https://doi.org/10.1177/1352458511399611

@article{e2637ae3eeb0494797d86159fdfc1efc,

title = "Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis",

author = "J.T. Phillips and G. Giovannoni and F.D. Lublin and P.W. O'Connor and C.H. Polman and E. Willoughby and W. Aschenbach and A. Pace and R. Hyde and F.E. Munschauer",

year = "2011",

doi = "https://doi.org/10.1177/1352458511399611",

language = "English",

volume = "17",

pages = "970--979",

journal = "Multiple sclerosis (Houndmills, Basingstoke, England)",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "8",

}

Phillips, JT, Giovannoni, G, Lublin, FD, O'Connor, PW, Polman, CH, Willoughby, E, Aschenbach, W, Pace, A, Hyde, R & Munschauer, FE 2011, 'Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis', MULTIPLE SCLEROSIS, vol. 17, no. 8, pp. 970-979. https://doi.org/10.1177/1352458511399611

Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis. / Phillips, J.T.; Giovannoni, G.; Lublin, F.D. et al.
In: MULTIPLE SCLEROSIS, Vol. 17, No. 8, 2011, p. 970-979.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis

AU - Phillips, J.T.

AU - Giovannoni, G.

AU - Lublin, F.D.

AU - O'Connor, P.W.

AU - Polman, C.H.

AU - Willoughby, E.

AU - Aschenbach, W.

AU - Pace, A.

AU - Hyde, R.

AU - Munschauer, F.E.

PY - 2011

Y1 - 2011

U2 - https://doi.org/10.1177/1352458511399611

DO - https://doi.org/10.1177/1352458511399611

M3 - Article

C2 - 21421809

SN - 1352-4585

VL - 17

SP - 970

EP - 979

JO - Multiple sclerosis (Houndmills, Basingstoke, England)

JF - Multiple sclerosis (Houndmills, Basingstoke, England)

IS - 8

ER -

Phillips JT, Giovannoni G, Lublin FD, O'Connor PW, Polman CH, Willoughby E et al. Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis. MULTIPLE SCLEROSIS. 2011;17(8):970-979. doi: https://doi.org/10.1177/1352458511399611